Interestingly, we found downregulation of several components (integrins α1/α5/α6, epithelial-stromal interaction 1 (EPSTI1), fibronectin type III) that may, together with altered MUC4 expression in cancer cells, modify epithelial-stromal interactions. Here, MUC4 is linked to cancer.